Loss of NPM2 expression is a potential immunohistochemical marker for malignant peritoneal mesothelioma: a single-center study of 92 cases.
Wu HL, Yang ZR, Su YD, Ma R, Du XM, Gao Y, Li Y. World J Surg Oncol. 2022 Oct 24; 20(1):350. Epub 2022 Oct 24.